Platinum

Platinum is not a metal your body needs or makes. It shows up in your urine for one of two reasons: you have been around it at work, or you were once treated with a platinum-based chemotherapy drug like cisplatin.

This test reflects how much platinum your kidneys are clearing. For most people the answer is close to zero, but for refinery workers, chemotherapy handlers, and cancer survivors it can stay detectable long after the exposure ends.

A Research and Monitoring Marker, Not a Routine Test

Urine platinum is used in three settings: monitoring workers exposed to platinum, checking background environmental exposure, and following people after platinum chemotherapy. It is an exposure marker, not a test with standardized clinical cutpoints, so a single number is best read alongside your exposure history rather than against a fixed "normal" line.

Because there are no universally agreed thresholds, the value of this test comes from knowing your own exposure story and watching how the number moves over time. That is exactly why getting a baseline now, and repeating it, gives you data to compare against as the science matures.

What the Number Actually Reflects

Platinum is an elemental metal, so the test measures the amount of platinum your kidneys are filtering out at the moment you give the sample. Urine is a convenient window into recently absorbed platinum, but the reading has to be corrected for how dilute your urine is, usually against creatinine, a waste product excreted at a fairly steady rate.

Higher values point to more recent or more retained platinum in the body. Lower values usually mean low exposure. What the number cannot do on its own is diagnose a disease, because the same value can mean very different things depending on whether it came from a refinery shift, a chemotherapy infusion, or ordinary city life.

Workplace Exposure Is the Clearest Use

Among precious-metals refinery workers, urine platinum cleanly separates high-exposure staff from lower-exposure coworkers, with a typical excretion around 0.21 micrograms per gram of creatinine (a dilution-corrected concentration unit) and much higher levels in directly exposed workers. In heavily exposed platinum-industry workers, values have reached roughly 1,000 times the level seen in unexposed people. The absorbed dose comes from both breathing in platinum dust and absorbing it through the skin, so urine platinum tracks total uptake, not just what is inhaled.

Hospital and pharmacy staff who prepare or give platinum chemotherapy show a milder version of this pattern. Older monitoring found platinum in a minority of samples and elevated readings in a couple of workers, with one pharmacist staying positive after handling stopped. In pharmacies using sealed isolators, urine platinum was measurable in everyone but not raised above unexposed controls, even when surfaces and gloves were contaminated.

After Platinum Chemotherapy, Platinum Lingers for Years

Once cisplatin has been given, platinum leaves the body slowly. In testicular cancer survivors, urine platinum fell with an estimated half-life of about 9.8 years (the range spanned roughly 7 to 13 years), and platinum has been detected in urine as long as 40 years after treatment. Circulating platinum in the same population declined with a terminal half-life near 3.7 years.

One caution matters here. The lab measures total platinum using a highly sensitive technique (ICP-MS, or inductively coupled plasma mass spectrometry), which cannot tell unchanged drug apart from platinum bound to proteins or other molecules. So a positive urine years after treatment confirms retained platinum, but not what form it is in or whether it is still biologically active.

Signals of Kidney Stress During Cisplatin

During active cisplatin treatment, urine platinum reflects the drug's disposition more than a clean diagnosis of kidney injury. In a small adult study, higher peak urine platinum tracked with several urinary markers of kidney stress by day 10, and a peak above roughly 24,000 nanograms per milliliter was proposed, in that research setting only, as an approximate marker of below-the-surface kidney injury. Treat that figure as a study finding, not a personal target.

In children treated with cisplatin, urine platinum measured within 24 hours of the infusion was linked to a higher drug dose and younger age, but not to clinically evident sudden kidney injury (acute kidney injury), not to the kidney-stress protein KIM-1, and only weakly to another such protein, NGAL. Separate work shows that urinary KIM-1, NGAL, cystatin C, and clusterin flag platinum-drug kidney damage earlier than blood creatinine does, so urine platinum is a supporting exposure signal rather than the best standalone early warning of kidney harm.

Late Effects in Cancer Survivors

In testicular cancer survivors, carrying more cumulative platinum over the years was linked to several lasting problems. Survivors who developed persistent nerve tingling had modestly more platinum exposure than those who did not (an exposure measure of 30.9 versus 27.0, about 14% higher), and the same direction held for low testosterone, higher LDL cholesterol, and high blood pressure.

This evidence has an important footnote. It came from modeled circulating platinum plus a single 24-hour urine collection, which is a related but different measurement from a spot urine platinum test. So it points to retained platinum mattering for long-term health, without proving that any one urine reading predicts these outcomes.

Environmental Background Is Usually Tiny

For people without occupational or medical exposure, urine platinum is generally very low, often around 5 nanograms per liter (a unit for extremely small concentrations). Traffic police exposed to platinum from catalytic converters showed essentially no difference from office workers (about 4.45 versus 4.56 nanograms per liter), suggesting ordinary traffic duty alone does not raise it meaningfully.

In a large study of midlife women, platinum was detectable in fewer than 5 out of 100 urine samples. At these low background levels, a single spot sample tells you little for the general population, and small contamination or an overlooked source can shift the interpretation more than any real change in your body.

When Results Can Be Misleading

Several factors can distort a single reading. Lead with timing: because these are the details most likely to send you to the wrong conclusion.

• Timing after exposure: after a single inhalation exposure, urine platinum peaks around 10 hours later and then falls with an initial half-life near 50 hours, so when you collect the sample changes the number.
• Hidden sources: dental alloys and silicone breast implants can raise background urine platinum, with implant users sometimes reading above typical background, so devices you may not think about can lift the result.
• Urine dilution: correcting for how concentrated your urine is (usually against creatinine) adds its own variability, and creatinine itself shifts with muscle mass, hydration, and other factors, making spot ratios less reproducible than they look.
• Kidney function: because platinum leaves mainly through the kidneys, changes in kidney function alter how much appears in urine independent of how much platinum you actually carry.

External contamination is also a real trap in monitoring. Collecting a first-morning sample, away from the work environment, is a standard way to reduce false highs from platinum on the skin or clothing rather than platinum genuinely absorbed into the body.

Why a Single Reading Rarely Tells the Whole Story

Urinary metals in general show large swings within the same person from day to day, and a single spot sample often captures only a short slice of exposure. That makes a trend far more informative than any one value, whether you are tracking a workplace exposure that should be falling or a chemotherapy legacy that fades over years.

A practical rhythm: take a baseline, then retest in 3 to 6 months if your exposure situation is changing, and at least annually otherwise. If you are being actively monitored at work, follow the occupational schedule and keep collection timing consistent so that changes reflect your body, not your calendar.

What an Unexpected Result Should Prompt

An out-of-pattern result is a starting point for a short workup, not a verdict. First, repeat it correctly: a first-morning sample collected away from any exposure, with urine creatinine measured alongside so the value can be dilution-corrected. Rule in or out obvious sources by reviewing recent work, dental alloys, implants, and any history of platinum chemotherapy.

From there, the pathway depends on the pattern. A high reading in someone with occupational exposure points toward an occupational medicine physician and a look at engineering controls and protective equipment. A high or persistent reading tied to past chemotherapy, especially with declining kidney numbers on companion tests like eGFR or cystatin C, is a conversation for a nephrologist or oncologist. Isolated low-level positivity with no exposure source and normal kidney markers usually warrants watchful retesting rather than aggressive action.